0.6340
+0.0010
+(0.16%)
At close: April 17 at 3:29:02 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -- | -- | -- | 1.3M |
| Low Estimate | -- | -- | -- | 1.3M |
| High Estimate | -- | -- | -- | 1.3M |
| Year Ago Sales | 9.27M | 10.2M | 47.98M | -- |
| Sales Growth (year/est) | -100.00% | -100.00% | -100.00% | 0.00% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| 2HA.F | -- | -- | -- | -- |
| S&P 500 | 6.92% | 4.87% | 8.58% | 14.16% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/30/2025 |
| Downgrade | Evercore ISI Group: Outperform to In-Line | 12/20/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 12/2/2024 |
| Downgrade | TD Cowen: Buy to Hold | 11/18/2024 |
| Reiterates | Cantor Fitzgerald: Overweight | 11/15/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/4/2024 |
Related Tickers
RPD.MU Royalty Pharma plc
28.29
+0.32%
05Y.MU Vivoryon Therapeutics NV
1.7140
0.00%
P0F.F Egetis Therapeutics AB (publ)
0.2835
-2.58%
HQ1.MU Oruka Therapeutics Inc. R
7.50
+2.04%
MVR0.BE Medivir AB
0.1372
-2.42%
BT3.BE Lineage Cell Therapeutics Inc
0.3600
-1.10%
ARDX.MX Ardelyx, Inc.
105.50
0.00%
PI3.DU Gubra AS
48.22
+2.42%
ICY.HA Incyte Corp
51.16
-0.31%
PROT Proteonomix, Inc.
0.0000
0.00%